FDA approves injectable semaglutide for people with obesity ages 12 and more Dr. Kamal Kant Kohli1 Jan 2023 8:00 PM ISTThe U.S. Food and Drug Administration (FDA) has approved a new indication for Wegovy (semaglutide) injection 2.4 mg, making it the first-and-only...
Health Bulletin 30/December/2022 Roshni Dhar30 Dec 2022 4:55 PM ISTHere are the top health news for the day:India reports 268 new Covid-19 infections; active cases rise to 3,552According to the Ministry of Health and...
Medical Bulletin 30/December/2022 Isra Zaman30 Dec 2022 10:30 AM ISTHere are the top medical news for the day:Based on ULTIMATE I & II trial results, novel drug BRIUMVI gets USFDA approval for relapsing forms of...
Based on ULTIMATE I & II trial results, novel drug BRIUMVI gets USFDA approval for relapsing forms of multiple sclerosis patients Isra Zaman30 Dec 2022 9:00 AM ISTTG Therapeutics recently announced the U.S.Food and Drug Administration (FDA) has approved BRIUMVI (ublituximab-xiiy),for the treatment of relapsing...
FDA Fast Tracks PH10 for Treatment of Major Depressive Disorder Dr. Kamal Kant Kohli28 Dec 2022 2:30 AM ISTAccording to a press release, the US Food and drug administration has granted fast track designation to a nasal spray PH10 for the treatment of major...
FDA approves abaloparatide for osteoporosis patients resistant to available treatment Dr. Kamal Kant Kohli25 Dec 2022 8:00 PM ISTThe Food and Drug Administration (FDA) has approved abaloparatide for the treatment osteoporosis among men at high risk for fracture or patients who...
FDA Approves Gene Therapy for Treating High-Risk, Non-Muscle-Invasive Bladder Cancer Dr. Kamal Kant Kohli20 Dec 2022 8:00 PM ISTThe Food and Drug Administration (FDA) has approved Adstiladrin (nadofaragene firadenovec-vncg) for treating high-risk, Bacillus Calmette-Guérin...
Medical Bulletin 20/December/2022 Isra Zaman20 Dec 2022 1:15 PM ISTHere are the top medical news for the day:Study finds metformin use to significantly reduce risk of joint replacement in people with type 2 diabetesA...
FDA approval to targeted imaging agent pafolacianine for use in lung cancer surgery Isra Zaman20 Dec 2022 10:00 AM ISTMore than 130,000 Americans die of lung cancer each year, making lung cancer the leading cause of cancer mortality in the country. Lung cancer...
FDA approves "glowing tumor" imaging agent Cytalux to aid lung cancer surgery Dr. Kamal Kant Kohli20 Dec 2022 9:00 AM ISTThe U.S. Food and Drug Administration (FDA) has approved the targeted imaging agent Cytalux (pafolacianine) for use in lung cancer surgery. This...
FDA Approves cariprazine as Adjunctive Treatment for Major Depressive Disorder Dr. Kamal Kant Kohli19 Dec 2022 10:00 AM ISTThe US Food and Drug Administration (FDA) has approved cariprazine (VRAYLAR) as an adjunctive therapy to antidepressants for the treatment of major...
Finerenone receives Grade A Recommendation for treating CKD patients associated with type 2 diabetes: AACE update Dr. Kamal Kant Kohli10 Dec 2022 8:00 PM ISTUSA: Bayer's KERENDIA (finerenone), a first-in-class non-steroidal mineralocorticoid receptor antagonist (ns-MRA) has received a grade A...
